CorticoMetrics LLC has been awarded a Phase I STTR grant by the NIH. The aim of the grant is to develop and evaluate software used for the detection of focal cortical dysplasias, a source of epileptic seizures.
Martinos Center News
The Martinos Center's Dylan Tisdall has received an NIH K99 award. The award is designed to help young investigators transition from the mentored to the independent phase of their career.
Martinos Center researcher Suzanne Corkin will be presenting on her book Permanent Present Tense at the 2013 Southern Festival of Books. The book explores the life of - and her work with - amnesiac patient H.M., often described as "the most famous brain in the world" as the decades of psychological tests and brain scans he underwent helped to shape our understandings of how memory works.
A Nature Medicine study by the Martinos Center's Kyrre Emblem and colleagues has garnered quite a bit of attention lately. Features about the work have appeared in NIH Research Matters, Nature Med podcasts (September issue), Aunt Minnie, AACR Cancer Discovery highlights, Voices Against Brain Cancer, The ASCO post and more.
A paper by Michael VanElzakker - a hypothesis of chronic fatigue syndrome - has been getting press.
Alok Jha of the Observer recently spoke with Martinos Center researcher Van Wedeen about his work with the connectome. Read what he had to say in "My life as a guinea pig for science."
The Martinos Center's Linda Douw has received a prestigious Branco Weiss Fellowship from the Society in Science. As a Branco Weiss fellow, Douw will explore the ways in which molecular processes give rise to behavior via the hypothesized intermediate level of brain networks in order to define new targets in the diagnosis and treatment of brain tumors.
Martinos Center faculty member Douglas Greve was recently elected to the post of Secretary of the Organization of Human Brain Mapping. He will serve on the OHBM executive council for the next three years but will not assume his role as Secretary until the 2014 OHBM meeting in Hamburg.
In the June 24 issue of The New Yorker, Jerome Groopman looks at efforts to treat Alzheimer's Disease preemptively, before any symptoms appear. This year, the NIH committed $36 million to a trial overseen by the Martinos Center's Reisa Sperling and Paul Aisen of the University of California, San Diego, to explore the possibility of preventing the disease.